Cargando…

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

Detalles Bibliográficos
Autores principales:	Nayar, Utthara, Lu, Pin, Vider, Jelena, Cerchietti, Leandro, Chiosis, Gabriela, Wang, Lynn, Blasberg, Ronald, Cesarman, Ethel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002695/ http://dx.doi.org/10.1186/1750-9378-5-S1-A36

Ejemplares similares

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
por: Shahinas, Dea, et al.
Publicado: (2013)

KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
por: Guasparri, Ilaria, et al.
Publicado: (2004)

Retraction: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
por: Guasparri, Ilaria, et al.
Publicado: (2021)

Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
por: Wen, Kwun Wah, et al.
Publicado: (2010)

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas
por: Calvo-Vidal, M. Nieves, et al.
Publicado: (2021)

KSHV induces immunoglobulin rearrangements in mature B lymphocytes
por: Totonchy, Jennifer, et al.
Publicado: (2018)

Systemic Expression of Kaposi Sarcoma Herpesvirus (KSHV) Vflip in Endothelial Cells Leads to a Profound Proinflammatory Phenotype and Myeloid Lineage Remodeling In Vivo
por: Ballon, Gianna, et al.
Publicado: (2015)

A purine scaffold Hsp90 inhibitor destabilizes Bcl6 and has specific anti-tumor activity in Bcl6 dependent B-cell lymphomas
por: Cerchietti, Leandro C, et al.
Publicado: (2009)

Physical plasma-triggered ROS induces tumor cell death upon cleavage of HSP90 chaperone
por: Bekeschus, Sander, et al.
Publicado: (2019)

Assay Strategies for the Discovery and Validation of Therapeutics Targeting Brugia pahangi Hsp90
por: Taldone, Tony, et al.
Publicado: (2010)

Selective inhibition of hsp90 paralogs: Structure and binding studies uncover the role of helix 1 in Grp94-selective ligand binding
por: Que, Nanette L. S., et al.
Publicado: (2023)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

KSHV regulation of fibulins in Kaposi’s sarcoma: implications for tumorigenesis
por: Alcendor, Donald, et al.
Publicado: (2010)

Tenth International Symposium on the Hsp90 chaperone machine: Switzerland, October 19-23, 2022
por: Edkins, Adrienne L., et al.
Publicado: (2023)

Development of a proteomic platform for EBV and KSHV serological screening
por: Wang, Leyao, et al.
Publicado: (2010)

Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes
por: Taldone, Tony, et al.
Publicado: (2013)

Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2017)

STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway
por: Liu, Yang, et al.
Publicado: (2017)

KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo
por: Pekkonen, Pirita, et al.
Publicado: (2014)

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
por: Azoitei, Ninel, et al.
Publicado: (2012)

Inhibition of KSHV-associated lymphoma engraftment in SCID mouse by morpholino oligomers
por: Nan, Yuchen, et al.
Publicado: (2010)

Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using (89)Zr-DFO-Trastuzumab
por: Holland, Jason P., et al.
Publicado: (2010)

C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
por: O’Farrell, Courtney, et al.
Publicado: (2010)

Current epidemiology of KSHV infection in American men who have sex with men
por: Labo, Nazzarena, et al.
Publicado: (2010)

KSHV interaction with Langerhans and dermal dendritic cells through C-type lectins
por: Rappocciolo, Giovanna, et al.
Publicado: (2010)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

Relationship between salivary shedding and seropositivity for Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not
por: Butler, Lisa, et al.
Publicado: (2010)

Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
por: Luo, Wenjie, et al.
Publicado: (2008)

Heat shock protein 90 in neurodegenerative diseases
por: Luo, Wenjie, et al.
Publicado: (2010)

cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries
por: Qi, Meifang, et al.
Publicado: (2021)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Systematic Analysis of a Xenograft Mice Model for KSHV(+) Primary Effusion Lymphoma (PEL)
por: Dai, Lu, et al.
Publicado: (2014)

Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
por: Li, Xiaojuan, et al.
Publicado: (2023)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Affinity Purification Probes of Potential Use To Investigate the Endogenous Hsp70 Interactome in Cancer
por: Rodina, Anna, et al.
Publicado: (2014)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_knjg6mevcq47dgtj59egv4ib4g